PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'King\'s College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK.\', \'MRC Centre for Neurodevelopmental Disorders, Institute of Psychiatry, Psychology and Neuroscience, King\'s College London, London, UK.\', \'Centre for Developmental Neurobiology, Institute of Psychiatry, Psychology and Neuroscience, King\'s College London, London, UK.\', \'Department of Infectious Diseases, Imperial College London, London, UK.\', \'Department of Infectious Diseases, School of Immunology & Microbial Sciences, King\'s College London, London, UK.\', \'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.\', \'International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy.\', \'Istituto di Biofisica (IBF), Consiglio Nazionale delle Ricerche (CNR), Trento, Italy.\', \'King\'s College London, British Heart Foundation Centre of Research Excellence, School of Cardiovascular Medicine & Sciences, London, UK. mauro.giacca@kcl.ac.uk.\', \'Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. mauro.giacca@kcl.ac.uk.\', \'International Centre for Genetic Engineering and Biotechnology (ICGEB), Trieste, Italy. mauro.giacca@kcl.ac.uk.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41586-021-03491-6
?:hasPublicationType
?:journal
  • Nature
is ?:pmid of
?:pmid
?:pmid
  • 33827113
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 17.875
?:rankingScore_hIndex
  • 1052
is ?:relation_isRelatedTo_publication of
?:title
  • Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all